06Jun
Supreme Court Decides Prescription Drug Preemption Case in Favor of Drug Manufacturer
The United States Supreme Court finally clarified its 11-year-old “clear evidence” standard for pharmaceutical preemption. In its much-anticipated opinion delivered by Justice Breyer, the Court unanimously reversed the Third Circuit’s holding that...
By:
Morrison & Foerster LLP - Class Dismissed
Related
While residential and commercial construction is currently considered an essential business activity...
Read More >
In 2013, Michael Dell and Silver Lake Group LLC took Dell, Inc. private through a leveraged buyout. ...
Read More >
In both the Commonwealth and New England — and, indeed, the country — these are exciting times for...
Read More >
Productivity loss claims are one of the biggest issues in construction arbitration and litigation. W...
Read More >
In June 2019, a unanimous Supreme Court in Kisor v. Wilkie retained but limited the scope of Auer de...
Read More >
On September 18, 2019, California Governor Gavin Newsom signed Assembly Bill (“AB”) 5, thereby cod...
Read More >